Children who were conceived through assisted reproductive technologies (ART) showed premature vascular ageing which persisted over 5 years and progressed to arterial hypertension in adolescence and young adulthood, thus placing them at an increased risk of developing cardiovascular (CV) disease even though no other classical CV risk factors were present, reveals a study.
Cardiac lesions in pregnant women are associated with a heightened risk of giving birth to small babies, particularly in subgroups of those with Fontan circulation, pulmonary arterial hypertension, prosthetic heart valves and systemic right ventricle, according to a study.
High-risk human papillomavirus (hrHPV) appears to improve cancer prognoses, such that women with hrHPV-positive cervical tumours have better survival than those negative for the infection, a recent study has found.
Newer molecular tests for high-risk human papillomavirus (hrHPV) may provide a cost-effective means for cervical cancer screening for low-to-middle income countries (LMICs), with results comparable to cervical biopsies.
Regular use of low-dose aspirin appears to protect against ovarian cancer risk, according to a recent study, which also reports that such risks may be exacerbated in those with long-term, high-quantity use of other analgesics.
Designed to ensure suitability for healthcare providers with limited training, the CRADLE Vital Signs Alert (VSA) is a device that integrates an evidence-based traffic light early warning system, which may enhance care for women in pregnancy, childbirth and in the postnatal period, according to a study.
A strong belief in the necessity of medication is associated with better adherence to oral disease-modifying antirheumatic drugs (DMARDs) or prednisone, while higher self-efficacy correlates with poor adherence, in a diverse cohort of patients with rheumatoid arthritis (RA), suggests a study.
Percutaneous coronary intervention (PCI) displays comparable rates of mortality and serious composite outcomes but a higher rate of target-vessel revascularization at 10 years relative to coronary artery bypass grafting (CABG) in patients with significant left main coronary artery (LMCA) disease, reports a study. On the other hand, CABG delivers lower mortality and serious composite outcome rates compared with PCI with drug-eluting stents after 5 years.
Apixaban slashes the risk of recurrent venous thromboembolism (VTE) by 90 percent in cancer patients compared with the low-molecular-weight heparin (LMWH) dalteparin, with no increase in major bleeding risk, according to the ADAM VTE study presented at ASH 2018.